# Sofinnova Partners' Biotech Investments: 66 Startups in Its Portfolio (2026) > The 66 Biotech startups Sofinnova Partners has backed, by stage: $5.9B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/sofinnova-partners-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 21 - [*CP* CinCor Pharma](https://millionrounds.com/company/cincor-pharma) - [*BP* Bionyra Pharma](https://millionrounds.com/company/bionyra-pharma) - [Redx Pharma](https://millionrounds.com/company/redx-pharma) - [Myricx Bio](https://millionrounds.com/company/myricx-bio) - [Alethio Therapeutics](https://millionrounds.com/company/alethio-therapeutics) - [Mnemo Therapeutics](https://millionrounds.com/company/mnemo-therapeutics) - [Actithera](https://millionrounds.com/company/actithera) - [*A* Accent](https://millionrounds.com/company/accent) - [POLYNEURON](https://millionrounds.com/company/polyneuron) - [Delinia](https://millionrounds.com/company/delinia) - [Mablink Bioscience](https://millionrounds.com/company/mablink-bioscience) - [Bon Vivant](https://millionrounds.com/company/bon-vivant) - [*CT* Comet Therapeutics](https://millionrounds.com/company/comet-therapeutics) - [Qorium](https://millionrounds.com/company/qorium) - [Leucid Bio](https://millionrounds.com/company/leucid-bio) - [Gradient Denervation Technologies](https://millionrounds.com/company/gradient-denervation-technologies) - [Freya Biosciences](https://millionrounds.com/company/freya-biosciences) - [AblaCare](https://millionrounds.com/company/ablacare) - [MedDay](https://millionrounds.com/company/medday) - [protera](https://millionrounds.com/company/protera) - [Nitrase Therapeutics](https://millionrounds.com/company/nitrase-therapeutics) ## Stage not reported 15 - [Abivax](https://millionrounds.com/company/abivax) - [Tenpoint Therapeutics](https://millionrounds.com/company/tenpoint-therapeutics) - [MISSION Therapeutics](https://millionrounds.com/company/mission-therapeutics) - [AFYREN](https://millionrounds.com/company/afyren) - [ProQR Therapeutics](https://millionrounds.com/company/proqr-therapeutics) - [HAYA Therapeutics](https://millionrounds.com/company/haya-therapeutics) - [Inotrem](https://millionrounds.com/company/inotrem) - [*I* Inventiva](https://millionrounds.com/company/inventiva) - [DOMAIN Therapeutics](https://millionrounds.com/company/domain-therapeutics) - [Microphyt](https://millionrounds.com/company/microphyt) - [Hookipa Pharma](https://millionrounds.com/company/hookipa-pharma) - [EnginZyme](https://millionrounds.com/company/enginzyme) - [*EM* Entourage Medical Technologies](https://millionrounds.com/company/entourage-medical-technologies) - [One Biosciences](https://millionrounds.com/company/one-biosciences) - [MetGen](https://millionrounds.com/company/metgen) ## Series B 13 - [T-Therapeutics](https://millionrounds.com/company/t-therapeutics) - [Mediar Therapeutics](https://millionrounds.com/company/mediar-therapeutics) - [Noema Pharma](https://millionrounds.com/company/noema-pharma) - [AAVantgarde Bio](https://millionrounds.com/company/aavantgarde-bio) - [GlycoEra](https://millionrounds.com/company/glycoera) - [Purespring Therapeutics](https://millionrounds.com/company/purespring-therapeutics) - [NodThera](https://millionrounds.com/company/nodthera) - [Mironid](https://millionrounds.com/company/mironid) - [GenSight Biologics](https://millionrounds.com/company/gensight-biologics) - [DNA Script](https://millionrounds.com/company/dna-script) - [*C* Corvidia](https://millionrounds.com/company/corvidia) - [Genespire](https://millionrounds.com/company/genespire) - [DMC Biotechnologies](https://millionrounds.com/company/dmc-biotechnologies) ## Series C and later 8 - [Hemab](https://millionrounds.com/company/hemab) - [HotSpot Therapeutics](https://millionrounds.com/company/hotspot-therapeutics) - [*AP* Amolyt Pharma](https://millionrounds.com/company/amolyt-pharma) - [*T* TISSIUM](https://millionrounds.com/company/tissium) - [Green Biologics](https://millionrounds.com/company/green-biologics) - [Shockwave Medical](https://millionrounds.com/company/shockwave-medical) - [Synthace](https://millionrounds.com/company/synthace) - [ENYO Pharma](https://millionrounds.com/company/enyo-pharma) ## Pre-seed and seed 6 - [Cure51](https://millionrounds.com/company/cure51) - [Home Biosciences](https://millionrounds.com/company/home-biosciences) - [Signadori Bio](https://millionrounds.com/company/signadori-bio) - [BioCorteX](https://millionrounds.com/company/biocortex) - [Alia Therapeutics](https://millionrounds.com/company/alia-therapeutics) - [*E* EnobraQ](https://millionrounds.com/company/enobraq) ## Growth 3 - [CellCentric](https://millionrounds.com/company/cellcentric) - [Innate Pharma](https://millionrounds.com/company/innate-pharma) - [Arzeda](https://millionrounds.com/company/arzeda) ## Segment by segment ### Series A 21 startups · $1.3B raised - [*CP* **CinCor Pharma**](https://millionrounds.com/company/cincor-pharma) CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases. United States $275M - [*BP* **Bionyra Pharma**](https://millionrounds.com/company/bionyra-pharma) France $165M - [**Redx Pharma**](https://millionrounds.com/company/redx-pharma) Redx Pharma is a drug discovery and development company. United Kingdom $127M - [**Myricx Bio**](https://millionrounds.com/company/myricx-bio) Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer. United Kingdom $115M - [**Alethio Therapeutics**](https://millionrounds.com/company/alethio-therapeutics) Alethio Therapeutics is a preclinical-stage biotechnology company based in Abingdon Science Park near Oxford, UK. United Kingdom $98M - [**Mnemo Therapeutics**](https://millionrounds.com/company/mnemo-therapeutics) Mnemo Therapeutics is a biotechnology company based in Paris, founded in 2019. France $90M - [**Actithera**](https://millionrounds.com/company/actithera) Actithera is a biotechnology company focused on developing next-generation radioligand therapies (RLTs) for cancer treatment. United Kingdom $76M - [*A* **Accent**](https://millionrounds.com/company/accent) United States $40M ### Stage not reported 15 startups · $1.5B raised - [**Abivax**](https://millionrounds.com/company/abivax) Abivax develops medicines that alter the body's natural immune system mechanisms. France $793M - [**Tenpoint Therapeutics**](https://millionrounds.com/company/tenpoint-therapeutics) Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics. United Kingdom $150M - [**MISSION Therapeutics**](https://millionrounds.com/company/mission-therapeutics) Mission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and developme United Kingdom $113M - [**AFYREN**](https://millionrounds.com/company/afyren) AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment. France $98M - [**ProQR Therapeutics**](https://millionrounds.com/company/proqr-therapeutics) Changing lives is what drives us at ProQR Therapeutics. Netherlands $68M - [**HAYA Therapeutics**](https://millionrounds.com/company/haya-therapeutics) HAYA Therapeutics, SA is a precision medicine and biotechnology company focused on developing innovative genomic medicines. Switzerland $67M - [**Inotrem**](https://millionrounds.com/company/inotrem) Inotrem is a French biotechnology company founded in 2013, based in Paris with a technology center in Nancy. France $66M - [*I* **Inventiva**](https://millionrounds.com/company/inventiva) France $44M ### Series B 13 startups · $1.5B raised - [**T-Therapeutics**](https://millionrounds.com/company/t-therapeutics) T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. United Kingdom $279M - [**Mediar Therapeutics**](https://millionrounds.com/company/mediar-therapeutics) Mediar Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2018-2019. United States $161M - [**Noema Pharma**](https://millionrounds.com/company/noema-pharma) Noema Pharma is a clinical-stage biotechnology company based in Basel, Switzerland, founded in 2019 by George Garibaldi and Luigi Costa. Switzerland $147M - [**AAVantgarde Bio**](https://millionrounds.com/company/aavantgarde-bio) AAVantgarde Bio is developing gene therapies for inherited retinal disorders. Italy $141M - [**GlycoEra**](https://millionrounds.com/company/glycoera) GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics. Switzerland $130M - [**Purespring Therapeutics**](https://millionrounds.com/company/purespring-therapeutics) Purespring Therapeutics is a clinical-stage company based in London, focused on precision nephrology. United Kingdom $128M - [**NodThera**](https://millionrounds.com/company/nodthera) NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases. United Kingdom $109M - [**Mironid**](https://millionrounds.com/company/mironid) Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer. United Kingdom $99M ### Series C and later 8 startups · $894M raised - [**Hemab**](https://millionrounds.com/company/hemab) Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Denmark $157M - [**HotSpot Therapeutics**](https://millionrounds.com/company/hotspot-therapeutics) HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment. United States $145M - [*AP* **Amolyt Pharma**](https://millionrounds.com/company/amolyt-pharma) Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. France $139M - [*T* **TISSIUM**](https://millionrounds.com/company/tissium) France $131M - [**Green Biologics**](https://millionrounds.com/company/green-biologics) Green Biologics offers fermentation technologies for the conversion of biomass to renewable fuels and chemicals. United Kingdom $118M - [**Shockwave Medical**](https://millionrounds.com/company/shockwave-medical) Shockwave Medical is a medical device company that develops Intravascular Lithotripsy (IVL) for treating calcified coronary diseases. United States $88M - [**Synthace**](https://millionrounds.com/company/synthace) Synthace is a London-based life sciences software company founded in 2011. United Kingdom $64M - [**ENYO Pharma**](https://millionrounds.com/company/enyo-pharma) ENYO Pharma is a clinical-stage biopharmaceutical company based in Lyon, France. France $54M ### Pre-seed and seed 6 startups · $58M raised - [**Cure51**](https://millionrounds.com/company/cure51) Cure51 is a Paris-based TechBio company founded in 2021, focused on creating a global clinical and multi-omics database of excepti France $16M - [**Home Biosciences**](https://millionrounds.com/company/home-biosciences) Home Biosciences is a biotechnology venture builder based in Paris, established in 2019. France $15M - [**Signadori Bio**](https://millionrounds.com/company/signadori-bio) Signadori Bio is the next-generation cellular immunotherapy for cancer cure. France $13M - [**BioCorteX**](https://millionrounds.com/company/biocortex) BioCorteX is a techbio company based in London, UK, founded in March 2021. United Kingdom $5.0M - [**Alia Therapeutics**](https://millionrounds.com/company/alia-therapeutics) Alia Therapeutics is an innovative biotechnology company based in Trento, Italy, founded in October 2018. Italy $4.8M - [*E* **EnobraQ**](https://millionrounds.com/company/enobraq) EnobraQ is a Toulouse-based biotechnology company. France $3.6M ### Growth 3 startups · $725M raised - [**CellCentric**](https://millionrounds.com/company/cellcentric) CellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK. United Kingdom $525M - [**Innate Pharma**](https://millionrounds.com/company/innate-pharma) Innate Pharma S.A. France $134M - [**Arzeda**](https://millionrounds.com/company/arzeda) We harness the power of Intelligent Protein Design TechnologyTM to create enzyme products solving industry's toughest challenges United States $65M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Sofinnova Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Sofinnova Partners portfolio map** 105 startups · $7.4B](https://millionrounds.com/portfolio-maps/sofinnova-partners-portfolio-map)[Co-investors **Who invests with Sofinnova Partners** 65 co-investors](https://millionrounds.com/portfolio-maps/sofinnova-partners-co-investors)[Investments abroad **Sofinnova Partners' investments in the United States** 20 startups · $1.1B](https://millionrounds.com/portfolio-maps/sofinnova-partners-investments-united-states)[Sector portfolio **Kima Ventures' AI portfolio** 79 startups · $975M](https://millionrounds.com/portfolio-maps/kima-ventures-ai-portfolio)[Sector portfolio **Kima Ventures' IT Services portfolio** 55 startups · $233M](https://millionrounds.com/portfolio-maps/kima-ventures-it-services-portfolio)[Sector portfolio **Kima Ventures' Fintech portfolio** 42 startups · $2.6B](https://millionrounds.com/portfolio-maps/kima-ventures-fintech-portfolio) ## Raising from investors like Sofinnova Partners? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)